ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1
Molyneux D, 2003. Lymphatic filariasis (elephantiasis) elimination: a public health success and development opportunity. Filaria J 2 :13.
-
2
World Health Organization, 2003. Global Programme to Eliminate Lymphatic Filariasis: Annual Report on Lymphatic Filariasis. Geneva: World Health Organization.
-
3
World Health Organization, 2001. Lymphatic filariasis. Wkly Epidemiol Rec 76 :149–156.
-
4
Michael D, Bundy DA, Grenfell BT, 1996. Re-assessing the global prevalence and distribution of lymphatic filariasis. Parasitology 112 :409–428.
-
5
Babu BV, Kar SK, 2004. Coverage, compliance and some operational issues of mass drug administration during the programme to eliminate lymphatic filariasis in Orissa, India. Trop Med Int Health 9 :702–709.
-
6
Ottesen EA, Duke BOL, Karam M, Behbehani K, 1997. Strategies and tools for the control/elimination of lymphatic filariasis. Bull World Health Organ 75 :491–503.
-
7
Stolk WA, Swaminathan S, van Oortmarssen GJ, Das PK, Habbema JD, 2003. Prospects for elimination of bancroftian filariasis by mass drug treatment in Pondicherry, India: a simulation study. J Infect Dis 188 :1371–1381.
-
8
de Rochars MF, Kanjilal S, Direny AN, Radday J, Lafontant JG, Mathieu E, Rheingans RD, Haddix AC, Streit TG, Beach MJ, Addiss DG, Lammie PJ, 2005. The Leogane, Haiti demonstration project: decreased microfilaremia and program costs after three years of mass drug administration. Am J Trop Med Hyg 73 :888–894.
-
9
Mathieu E, Direny AN, de Rochars MB, Streit TG, Addiss DG, Lammie PJ, 2006. Participation in three consecutive mass drug administrations in Leogane, Haiti. Am J Trop Med Hyg 11 :862–868.
-
10
Pichon G, 2002. Limitation and facilitation in the vectors and other aspects of the dynamics of filarial transmission: the need for vector control against Anopheles-transmitted filariasis. Ann Trop Med Parasitol 96 :S143–S153.
-
11
Esterre P, Plichart C, Sechan Y, Nguen L, 2001. The impact of 34 years of massive DEC chemotherapy on Wuchereria bancrofti infection and transmission: the Maupiti cohort. Trop Med Int Health 6 :190–195.
-
12
Mathieu E, Lammie PJ, Radday J, Beach MJ, Streit T, Wendt J, Addiss DG, 2004. Factors associated with participation in a campaign of mass treatment against lymphatic filariasis in Leogane, Haiti. Ann Trop Med Parasitol 98 :703–714.
-
13
Ramaiah KD, Das PK, Appavoo NC, Ramu K, Augustin DJ, Vijay Kurnar KN, Chandrakala AV, 2000. A program to eliminate lymphatic filariasis in Tamil Nadu state, India compliance with annual single-dose DEC mass treatment and some related operational aspects. Trop Med Int Health 5 :842–847.
-
14
de Rochars M, Direny AN, Roberts JM, Addiss DG, Radday J, Beach MJ, Streit TG, Dardith D, Lafontant JG, Lammie PJ, 2004. Community-wide reduction in prevalence and intensity of intestinal helminths as a collateral benefit of lymphatic filariasis elimination programs. Am J Trop Med Hyg 71 :466–470.
-
15
Brady MA, Hooper PJ, Ottesen EA, 2006. Projected benefits from integrating NTD programs in sub-Saharan Africa. Trends Parasitol 22 :285–291.
-
16
World Health Organization, 2006. Preventive Chemotherapy in Human Helminthiasis: Coordinated Use of Anthelminthic Drugs in Control Interventions; A Manual for Health Professionals and Programme Managers. Geneva: World Health Organization.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 400 | 359 | 48 |
| Full Text Views | 222 | 3 | 1 |
| PDF Downloads | 67 | 3 | 1 |
Predictors of Compliance in Mass Drug Administration for the Treatment and Prevention of Lymphatic Filariasis in Leogane, Haiti
Jeffrey T. Talbot
Jeffrey T. Talbot
Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia; Division of Parasitic Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia; Hopital Ste. Croix, Leogane, Haiti; Center for Tropical Disease Research and Training, University of Notre Dame, Notre Dame, Indiana
Search for other papers by Jeffrey T. Talbot in
Current site
Google Scholar
PubMed
Search for other papers by Jeffrey T. Talbot in
Current site
Google Scholar
PubMed
Abigail Viall
Abigail Viall
Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia; Division of Parasitic Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia; Hopital Ste. Croix, Leogane, Haiti; Center for Tropical Disease Research and Training, University of Notre Dame, Notre Dame, Indiana
Search for other papers by Abigail Viall in
Current site
Google Scholar
PubMed
Search for other papers by Abigail Viall in
Current site
Google Scholar
PubMed
Abdel Direny
Abdel Direny
Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia; Division of Parasitic Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia; Hopital Ste. Croix, Leogane, Haiti; Center for Tropical Disease Research and Training, University of Notre Dame, Notre Dame, Indiana
Search for other papers by Abdel Direny in
Current site
Google Scholar
PubMed
Search for other papers by Abdel Direny in
Current site
Google Scholar
PubMed
Madsen Beau de Rochars
Madsen Beau de Rochars
Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia; Division of Parasitic Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia; Hopital Ste. Croix, Leogane, Haiti; Center for Tropical Disease Research and Training, University of Notre Dame, Notre Dame, Indiana
Search for other papers by Madsen Beau de Rochars in
Current site
Google Scholar
PubMed
Search for other papers by Madsen Beau de Rochars in
Current site
Google Scholar
PubMed
David Addiss
David Addiss
Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia; Division of Parasitic Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia; Hopital Ste. Croix, Leogane, Haiti; Center for Tropical Disease Research and Training, University of Notre Dame, Notre Dame, Indiana
Search for other papers by David Addiss in
Current site
Google Scholar
PubMed
Search for other papers by David Addiss in
Current site
Google Scholar
PubMed
Thomas Streit
Thomas Streit
Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia; Division of Parasitic Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia; Hopital Ste. Croix, Leogane, Haiti; Center for Tropical Disease Research and Training, University of Notre Dame, Notre Dame, Indiana
Search for other papers by Thomas Streit in
Current site
Google Scholar
PubMed
Search for other papers by Thomas Streit in
Current site
Google Scholar
PubMed
Els Mathieu
Els Mathieu
Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia; Division of Parasitic Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia; Hopital Ste. Croix, Leogane, Haiti; Center for Tropical Disease Research and Training, University of Notre Dame, Notre Dame, Indiana
Search for other papers by Els Mathieu in
Current site
Google Scholar
PubMed
Search for other papers by Els Mathieu in
Current site
Google Scholar
PubMed
Patrick J. Lammie
Patrick J. Lammie
Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia; Division of Parasitic Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia; Hopital Ste. Croix, Leogane, Haiti; Center for Tropical Disease Research and Training, University of Notre Dame, Notre Dame, Indiana
Search for other papers by Patrick J. Lammie in
Current site
Google Scholar
PubMed
Search for other papers by Patrick J. Lammie in
Current site
Google Scholar
PubMed
The global strategy for the elimination of lymphatic filariasis (LF) is based on annual mass drug administration (MDA) to interrupt transmission. Noncompliance with MDA represents a serious programmatic obstacle for the LF program because systematically noncompliant individuals may serve as a reservoir for the parasite and permit recrudescence of infection. Using a survey questionnaire concerning practices, beliefs, and attitudes towards MDA, we assessed differences between noncompliant individuals and compliant individuals in Leogane, Haiti (n = 367) after four years of treatment. A logistic regression model showed the odds of being noncompliant were significantly increased for women (odds ratio = 2.74, 95% confidence interval = 1.12–6.70), as well as for people who lacked knowledge about both LF and programs to eliminate infection. Public health programs should be designed to target people who are at risk for systematic noncompliance.
Author Notes
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1
Molyneux D, 2003. Lymphatic filariasis (elephantiasis) elimination: a public health success and development opportunity. Filaria J 2 :13.
-
2
World Health Organization, 2003. Global Programme to Eliminate Lymphatic Filariasis: Annual Report on Lymphatic Filariasis. Geneva: World Health Organization.
-
3
World Health Organization, 2001. Lymphatic filariasis. Wkly Epidemiol Rec 76 :149–156.
-
4
Michael D, Bundy DA, Grenfell BT, 1996. Re-assessing the global prevalence and distribution of lymphatic filariasis. Parasitology 112 :409–428.
-
5
Babu BV, Kar SK, 2004. Coverage, compliance and some operational issues of mass drug administration during the programme to eliminate lymphatic filariasis in Orissa, India. Trop Med Int Health 9 :702–709.
-
6
Ottesen EA, Duke BOL, Karam M, Behbehani K, 1997. Strategies and tools for the control/elimination of lymphatic filariasis. Bull World Health Organ 75 :491–503.
-
7
Stolk WA, Swaminathan S, van Oortmarssen GJ, Das PK, Habbema JD, 2003. Prospects for elimination of bancroftian filariasis by mass drug treatment in Pondicherry, India: a simulation study. J Infect Dis 188 :1371–1381.
-
8
de Rochars MF, Kanjilal S, Direny AN, Radday J, Lafontant JG, Mathieu E, Rheingans RD, Haddix AC, Streit TG, Beach MJ, Addiss DG, Lammie PJ, 2005. The Leogane, Haiti demonstration project: decreased microfilaremia and program costs after three years of mass drug administration. Am J Trop Med Hyg 73 :888–894.
-
9
Mathieu E, Direny AN, de Rochars MB, Streit TG, Addiss DG, Lammie PJ, 2006. Participation in three consecutive mass drug administrations in Leogane, Haiti. Am J Trop Med Hyg 11 :862–868.
-
10
Pichon G, 2002. Limitation and facilitation in the vectors and other aspects of the dynamics of filarial transmission: the need for vector control against Anopheles-transmitted filariasis. Ann Trop Med Parasitol 96 :S143–S153.
-
11
Esterre P, Plichart C, Sechan Y, Nguen L, 2001. The impact of 34 years of massive DEC chemotherapy on Wuchereria bancrofti infection and transmission: the Maupiti cohort. Trop Med Int Health 6 :190–195.
-
12
Mathieu E, Lammie PJ, Radday J, Beach MJ, Streit T, Wendt J, Addiss DG, 2004. Factors associated with participation in a campaign of mass treatment against lymphatic filariasis in Leogane, Haiti. Ann Trop Med Parasitol 98 :703–714.
-
13
Ramaiah KD, Das PK, Appavoo NC, Ramu K, Augustin DJ, Vijay Kurnar KN, Chandrakala AV, 2000. A program to eliminate lymphatic filariasis in Tamil Nadu state, India compliance with annual single-dose DEC mass treatment and some related operational aspects. Trop Med Int Health 5 :842–847.
-
14
de Rochars M, Direny AN, Roberts JM, Addiss DG, Radday J, Beach MJ, Streit TG, Dardith D, Lafontant JG, Lammie PJ, 2004. Community-wide reduction in prevalence and intensity of intestinal helminths as a collateral benefit of lymphatic filariasis elimination programs. Am J Trop Med Hyg 71 :466–470.
-
15
Brady MA, Hooper PJ, Ottesen EA, 2006. Projected benefits from integrating NTD programs in sub-Saharan Africa. Trends Parasitol 22 :285–291.
-
16
World Health Organization, 2006. Preventive Chemotherapy in Human Helminthiasis: Coordinated Use of Anthelminthic Drugs in Control Interventions; A Manual for Health Professionals and Programme Managers. Geneva: World Health Organization.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 400 | 359 | 48 |
| Full Text Views | 222 | 3 | 1 |
| PDF Downloads | 67 | 3 | 1 |